Inflammation, inadequate dialysis, hyperparathyroidism, and use of angiotensin receptor blockers or angiotensin-converting enzyme inhibitors are associated with ESA-resistant anemia in patients undergoing hemodialysis18. The gene discussed is ACE; the disease is anemia (phenotype).